Estée Lauder Companies (The) (EL)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
$103.86+2.97%
Close 2026-09-04 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-04
Intact: The reason to own it still holds.
Estée Lauder is growing sales about 5% yearly with improving profit margins near 15%. The company is cutting costs and boosting free cash flow to nearly $900 million. Its Beauty Reimagined strategy is restoring growth and profitability. The stock trades at a premium but reflects solid execution and growth.
Growth could slow below 2% if consumer demand weakens. Profit margins might shrink if cost savings stall. The stock is expensive at 38 times earnings, risking a valuation pullback.
The market prices in about 5% revenue growth and a stretched valuation 29% above our fair value near $65. Our fair value is 23% below the Street median. We see execution risks that could pressure growth and margins.
Breaks if: adjusted operating margin falls below 10% next year
Continue expanding adjusted operating margin toward a solid double-digit margin, targeting 12.7% to 13.5% in fiscal 2027.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround opportunity in the Consumer Staples sector. The current thesis state is cautious, as the company has shown mixed results and faces headwinds.
The market currently prices EL at an expensive valuation compared to peers, with a significant expectations gap. This suggests that investors may be anticipating better performance than what has been delivered recently.
Management is focused on accelerating organic sales growth and expanding margins, with recent results showing progress in these areas. However, the company remains loss-making, which adds to the uncertainty around its future performance.
Key factors for the future include the company's ability to maintain guidance without cuts, the impact of inflation on consumer behavior, and the performance of sector leaders like PG, UL, and CL. Any shifts in these areas could significantly influence EL's trajectory.
The most important moves since the prior daily snapshot.
Signal changed from 'mild_favorable' to 'mixed'.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats impacting the thesis at this time.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 6 of last 6 quarters. Adjusted operating margin improved from 8.0% in fiscal 2025 to 11.2% in fiscal 2026, with guidance raising the outlook to 12.7% to 13.5% for fiscal 2027. The trajectory is delivering consistent margin expansion aligned with management's stated goals.
“Raises Outlook on Adjusted Operating Margin to 12.7% to 13.5%.”
“Adjusted Operating Margin expanded 290 basis points to 14.4%.”
“Adjusted Operating Margin expanded 300 basis points to 7.3%.”
“Pursuit of a solid double-digit adjusted operating margin over the next few years.”
“Adjusted Operating Margin contracted 270 basis points to 11.4%.”
“Adjusted Operating Margin contracted 200 basis points to 11.5%.”
Breaks if: capital expenditures exceed $1.7B in FY27
Breaks if: free cash flow falls below $600M next year
Breaks if: organic sales growth falls below 2% YoY next year
Continue to drive organic sales growth across all regions and product categories, aiming for 3% to 5% growth in fiscal 2027.
Stated as a priority in 6 of last 6 quarters. Organic net sales grew from 3% in fiscal 2025-Q4 to 5% in fiscal 2026-Q3, with management affirming 3% to 5% growth guidance for fiscal 2027. The trajectory matches management's stated goal of accelerating organic sales growth.
“Organic net sales growth of 3% to 5% for fiscal 2027 affirmed.”
“Raised fiscal 2026 outlook reflecting solid performance and organic sales growth.”
“Organic sales for Fragrance rose double-digits; momentum across all priorities of Beauty Reimagined.”
“Confident in outlook to deliver organic sales growth this year after three years of declines.”
“Delivered organic sales outlook and exceeded profitability expectations.”
“Launched Beauty Reimagined to restore sustainable sales growth.”
Over the next 1 to 3 years, EL's performance will depend on its execution of strategic priorities and external market conditions. Not investment advice.